Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-25T08:13:37.408Z Has data issue: false hasContentIssue false

Chapter 21 - Prescribing for Health Issues in Women with Intellectual Disability

Published online by Cambridge University Press:  07 November 2024

David M. L. Branford
Affiliation:
Independent Pharmacy Consultant
Satheesh K. Gangadharan
Affiliation:
Leicestershire Partnership NHS Trust
Mary Barrett
Affiliation:
Leicestershire Partnership NHS Trust
Regi T. Alexander
Affiliation:
Hertfordshire Partnership University NHS Foundation Trust
Get access

Summary

People with intellectual disability are as likely to experience menstrual cycle-related mental problems as the general population; however, there may be problems in recognition and communication. Exploration of these health problems and potential treatments associated with menstrual cycle, from puberty through to menopause, are discussed.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2024

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bargiota, A. & Diamanti-Kandarakis, E. (2012) The effects of old, new, and emerging medicines on metabolic aberrations in PCOS. Therapeutic Advances in Endocrinology and Metabolism, 3(1), 2747.CrossRefGoogle ScholarPubMed
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B.. (2016) The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis, Human Reproduction, 31(12), 2841–55.CrossRefGoogle ScholarPubMed
Brown, H. (1996). Ordinary women: Issues for women with learning disabilities. British Journal of Learning Disabilities, 24(2), 4751. https://doi.org/10.1111/j.1468-3156.1996.tb00201.xCrossRefGoogle Scholar
Christian, C. A., Reddy, D. S., Maguire, J., & Forcelli, P. A. (2020). Sex differences in the epilepsies and associated comorbidities: Implications for use and development of Pharmacotherapies. Pharmacological Reviews, 72(4), 767800. https://doi.org/10.1124/pr.119.017392CrossRefGoogle ScholarPubMed
Cooper, N. C., Balachandran Nair, D., Egan, S., Barrie, A., & Perera, B. (2019). Current evidence for the identification and management of premenstrual syndrome in women with intellectual disabilities: A systematic review. Advances in Mental Health and Intellectual Disabilities, 13(6), 268–83. https://doi.org/10.1108/amhid-05-2019-0015CrossRefGoogle Scholar
Dilbaz, B., & Aksan, A. (2021). Premenstrual syndrome, a common but underrated entity: Review of the clinical literature. Journal of the Turkish-German Gynecological Association, 22(2), 139–48. https://doi.org/10.4274/jtgga.galenos.2021.2020.0133CrossRefGoogle ScholarPubMed
Duncan, S., Read, C. L., & Brodie, M. J. (1993). How common is catamenial epilepsy? Epilepsia, 34(5), 827–31.CrossRefGoogle ScholarPubMed
Dural, Ö., Taş, İ. S., & Akhan, S. E. (2020). Management of menstrual and gynecologic concerns in girls with special needs. Journal of Clinical Research in Pediatric Endocrinology, 12(1), 41–5. https://doi.org/10.4274/jcrpe.galenos.2019.2019.s0174CrossRefGoogle ScholarPubMed
Feely, M., Calvert, R., & Gibson, J. (1982). Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants. Lancet, 10(2), 71--3. https://doi.org/10.1016/s0140-6736(82)91691-9.Google Scholar
Gao, M., Cheng, X., Zhang, H., et al. (2021). Global and regional prevalence and burden for premenstrual syndrome and premenstrual dysphoric disorder: A study protocol for systematic review and meta-analysis. Medicine (Baltimore), 101(1), e28528. https://doi.org/10.37766/inplasy2021.12.0065CrossRefGoogle Scholar
Goodman, A. (2006). SNRI antidepressant reduces postmenopausal hot flashes. American Congress of Obstetricians and Gynecologists (ACOG) 59th Annual Clinical Meeting.Google Scholar
Goodman, N. F., Cobin, R. H., Ginzburg, S. B., et al. (2011). American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause. Endocrine Practice, 17, 125.CrossRefGoogle Scholar
Green, L. J., O’Brien, P. M.S., Panay, N., & Craig, M. on behalf of the Royal College of Obstetricians and Gynaecologists (2017). Management of premenstrual syndrome. BJOG, 124, e73e105.Google Scholar
Hanlon, P., MacDonald, S., Wood, K., Allan, L., & Cooper, S.-A. (2018). Long-term condition management in adults with intellectual disability in primary care: A systematic review. BJGP Open, 2(1). https://doi.org/10.3399/bjgpopen18x101445CrossRefGoogle ScholarPubMed
Hoeger, K. M., Dokras, A., & Piltonen, T. (2020). Update on PCOS: Consequences, challenges, and guiding treatment. The Journal of Clinical Endocrinology & Metabolism, 106(3). https://doi.org/10.1210/clinem/dgaa839Google Scholar
Hickey, M., Elliott, J., & Davison, S. L. (2012) Hormone replacement therapy. BMJ; 344, e763.CrossRefGoogle ScholarPubMed
Landen, M., Eriksson, O., Sundblad, C., et.al. (2001) Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: A comparison of buspirone, nefazodone and placebo. Psychopharmacology; 155, 292–8.Google ScholarPubMed
Maltais, J., Morin, D., & Tassé, M. J. (2020). Healthcare services utilization among people with intellectual disability and comparison with the general population. Journal of Applied Research in Intellectual Disabilities, 33(3), 552–64. https://doi.org/10.1111/jar.12698CrossRefGoogle ScholarPubMed
Martin, D. M., Kakumani, S., Martin, M. S., & Cassidy, G. (2003). Learning disabilities and the menopause. The Journal of the British Menopause Society, 9(1), 22–6. https://doi.org/10.1258/136218003100322107CrossRefGoogle ScholarPubMed
Maguire, M. J., & Nevitt, S. J. (2021). Treatments for seizures in catamenial (menstrual‐related) epilepsy. Cochrane Database of Systematic Reviews, 9. Art. No.: CD013225. https://doi.org/10.1002/14651858.CD013225.pub3.Google ScholarPubMed
Nelson, H. D. et al. (2006) Nonhormonal therapies for menopausal hot flashes systematic review and meta-analysis. Journal of American Medical Association, JAMA, 295(17), 2057–71.CrossRefGoogle ScholarPubMed
O’Hara, J. (2004) Mental Health needs of women with learning disabilities: Services can be organised to meet the challenge; (Commentary) – Learning Disability Review: 9(4), 20–3.Google Scholar
Panay, N., Hamoda, H., Arya, R. & Savvas, M. (2013) The 2013 British Menopause Society Women’s Health concern and recommendations on Hormone Replacement Therapy. Published online, 19(2), 5968. http://min.sagepub.com/content/19/2/59.full.pdf+htmlCrossRefGoogle Scholar
Paul, S. & Pal, A. (2022). Premenstrual syndrome and premenstrual dysphoric disorder: A review of their history with an eye on future. Annals of Indian Psychiatry. https://doi.org/10.4103/aip.aip_16_22.CrossRefGoogle Scholar
Perera, B., Audi, S., Solomou, S., Courtenay, K., & Ramsay, H. (2019). Mental and physical health conditions in people with intellectual disabilities: Comparing local and national data. British Journal of Learning Disabilities, 48(1), 1927. https://doi.org/10.1111/bld.12304CrossRefGoogle Scholar
Plourde, N., Brown, H. K., Vigod, S., & Cobigo, V. (2018). The association between continuity of primary care and preventive cancer screening in women with intellectual disability. American Journal on Intellectual and Developmental Disabilities, 123(6), 499513. https://doi.org/10.1352/1944-7558-123.6.499.CrossRefGoogle ScholarPubMed
Stolberg, M. (2000). The monthly malady: A history of premenstrual suffering. Medical History, 44(3), 301–22.CrossRefGoogle ScholarPubMed
Tiranini, L., & Nappi, R. E. (2022). Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome. Faculty Reviews, 11. https://doi.org/10.12703/r/11-11CrossRefGoogle ScholarPubMed
Verrotti, A., D’Egidio, C., Agostinelli, S., Verrotti, C., & Pavone, P. (2012). Diagnosis, and management of catamenial seizures: A review. International Journal of Women’s Health, 4, 535–41. https://doi.org/10.2147/IJWH.S28872.Google ScholarPubMed
Wiseman, P., & Ferrie, J. (2020). Reproductive (in)justice and inequality in the lives of women with intellectual disabilities in Scotland. Scandinavian Journal of Disability Research, 22(1), 318–29. https://doi.org/10.16993/sjdr.677.CrossRefGoogle Scholar
World Health Organization. (2019/2021). ICD-11: International classification of diseases (11th revision). https://icd.who.int/.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×